Investing in the pharmaceutical sector has always been rewarding and even though some of the companies in your portfolio, like Merck, might be old enough to be called veterans, they are still worthy enough to provide healthy returns. Merck & Co Inc (NYSE:MRK) proved the veracity of its survival skills yet again as it made…